Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features (2020)
- Authors:
- USP affiliated authors: NOUSHMEHR, HOUTAN - FMRP ; MOSELLA, MARITZA QUEIROZ SALAS - FMRP
- Unidade: FMRP
- DOI: 10.1158/1557-3265.LiqBiop20-A11
- Subjects: METILAÇÃO DE DNA; GLÂNDULA PITUITÁRIA; NEOPLASIAS; BIÓPSIA; GLIOMA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2020
- Source:
- Título: Clinical Cancer Research
- ISSN: 1557-3265
- Volume/Número/Paginação/Ano: v. 26, n. 11, supl., res. A11, 2020
- Conference titles: AACR Special Conference on Advances in Liquid Biopsies
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WELLS, Michael et al. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A11. Acesso em: 25 fev. 2026. , 2020 -
APA
Wells, M., Asmaro, karam, Sabedot, T., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2020). Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A11 -
NLM
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11 -
Vancouver
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11 - DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas
- Glioma cell-free DNA methylation marker for diagnosis and monitoring
- Epigenome analysis of pituitary adenomas define candidate master regulators
- Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies
- DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors
- Efeito do gene Autoimmune regulator (Aire) sobre a expressão de RNAs longos não codificadores em células tímicas epiteliais medulares
- DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features
- TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages [version 2; referees: 1 approved, 2 approved with reservations]
- The cancer genome atlas pan-cancer analysis project
- The somatic genomic landscape of glioblastoma
Informações sobre o DOI: 10.1158/1557-3265.LiqBiop20-A11 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
